ABGABEVORRICHTUNG

Patent europeic · EP1644063 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1644063
Numer da la dumonda
EP04743099
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-06-2004
Publitgà
12-04-2006
Concedì
27-12-2017
Stritgà
28-06-2024
Motiv
Durada maximala cuntanschida
Classas IPC
A61M 15/00 (2006.01)
Prioritad
GB 0315509 02.07.2003
Dumonda PCT
PCT/GB2004/002748 25.06.2004
Publicaziun PCT
WO2005/002654 13.01.2005
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 28-06-2024

    Durada maximala cuntanschida

    Published in Swissreg on 28.06.2024

  2. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  3. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  4. 27-12-2017

    Concedì

    Published in Swissreg on 27.12.2017

Partidas

Possessur

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, GB

Inventur

HOUZEGO, Peter John

Oakington, Cambridge CB4 5AD, GB

CONWAY, John Kelshaw

Sawston, Cambridge CB2 4DJ, GB

PEARL, Martin Douglas

Over, Cambridgeshire CB4 5PU, GB

BRYANT, Andrew Mark

Cambridgeshire SG8 5JG, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.